VANGUARD GROUP INC 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:08 pm Purchase | 2023-12-29 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | VANGUARD GROUP INC | 1,574,742 7.980% | 308,367 (+24.35%) | Filing |
| 2023-02-09 11:25 am Purchase | 2022-12-30 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | VANGUARD GROUP INC | 1,266,375 7.400% | 143,314 (+12.76%) | Filing |
| 2022-02-10 08:22 am Purchase | 2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | VANGUARD GROUP INC | 1,123,061 6.570% | 234,643 (+26.41%) | Filing |
| 2021-02-10 11:22 am Purchase | 2020-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | VANGUARD GROUP INC | 888,418 5.740% | 102,977 (+13.11%) | Filing |
| 2020-02-11 4:44 pm Purchase | 2019-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL | VANGUARD GROUP INC | 785,441 5.090% | 785,441 (New Position) | Filing |